N. Nikolić

发表

Hyperfractionated radiation therapy for incompletely resected supratentorial low-grade glioma. A phase II study.

B. Jeremic, Y. Shibamoto, D. Grujičić, 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Concurrent radiochemotherapy for patients with stage III non-small-cell lung cancer (NSCLC): long-term results of a phase II study.

B. Jeremic, Y. Shibamoto, B. Miličić, 1998, International journal of radiation oncology, biology, physics.

Impact of treatment interruptions due to toxicity on outcome of patients with early stage (I/II) non-small-cell lung cancer (NSCLC) treated with hyperfractionated radiation therapy alone.

B. Jeremic, Y. Shibamoto, B. Miličić, 2003, Lung cancer.

Second C ancers O ccurring i n P atients W ith E arly S tage Non-Small-Cell L ung C ancer T reated W ith C hest Radiation T herapy A lone

B. Jeremic, Y. Shibamoto, N. Nikolić, 2013 .

Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: A randomized study.

B. Jeremic, Y. Shibamoto, B. Miličić, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

External beam radiation therapy alone for loco-regional recurrence of non-small-cell lung cancer after complete resection.

B. Jeremic, Y. Shibamoto, B. Miličić, 1999, Lung cancer.

[Association between clinical parameters and the presence of Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis in patients with progressive periodontal lesions].

B. Miličić, N. Nikolić, D. Pavlica, 2010, Vojnosanitetski pregled.

Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: a randomized trial.

B. Jeremic, Y. Shibamoto, B. Miličić, 2001, International journal of radiation oncology, biology, physics.

Prolonged administration of oral etoposide alone or with intravenous carboplatin in stage IV non-small cell lung cancer: a randomized trial.

B. Jeremic, Y. Shibamoto, B. Miličić, 1997, Lung cancer.

Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial.

B. Jeremic, Y. Shibamoto, B. Miličić, 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Influence of interfraction interval on the efficacy and toxicity of hyperfractionated radiotherapy in combination with concurrent daily chemotherapy in stage III non-small-cell lung cancer.

B. Jeremic, Y. Shibamoto, B. Miličić, 2001, International journal of radiation oncology, biology, physics.

A phase II study of concurrent accelerated hyperfractionated radiotherapy and carboplatin/oral etoposide for elderly patients with stage III non-small-cell lung cancer.

B. Jeremic, Y. Shibamoto, B. Miličić, 1999, International journal of radiation oncology, biology, physics.

A randomized trial of three single-dose radiation therapy regimens in the treatment of metastatic bone pain.

B. Jeremic, Y. Shibamoto, B. Miličić, 1998, International journal of radiation oncology, biology, physics.

Prolonged oral versus high-dose intravenous etoposide in combination with carboplatin for stage IV non-small-cell lung cancer (NSCLC): a randomized trial.

B. Jeremic, Y. Shibamoto, B. Miličić, 1999, Lung cancer.

Pretreatment clinical prognostic factors in patients with stage IV non-small cell lung cancer (NSCLC) treated with chemotherapy

B. Jeremic, B. Miličić, N. Nikolić, 2003, Journal of Cancer Research and Clinical Oncology.

Short-term chemotherapy and palliative radiotherapy for elderly patients with stage IV non-small cell lung cancer: a phase II study.

B. Jeremic, Y. Shibamoto, B. Miličić, 1999, Lung cancer.

Combined Treatment Modality for Anaplastic Oligodendroglioma: A Phase II Study

B. Jeremic, Y. Shibamoto, D. Grujičić, 1999, Journal of Neuro-Oncology.

Hyperfractionated Radiation Therapy With or Without Concurrent Low-Dose Daily Cisplatin in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Prospective Randomized Trial

B. Jeremic, Y. Shibamoto, B. Miličić, 2000 .

Clinical Prognostic Factors in Patients With Malignant Glioma Treated With Combined Modality Approach

B. Jeremic, D. Grujičić, B. Miličić, 2004, American journal of clinical oncology.

Accelerated hyperfractionated radiation therapy and concurrent 5-fluorouracil/cisplatin chemotherapy for locoregional squamous cell carcinoma of the thoracic esophagus: a phase II study.

B. Jeremic, Y. Shibamoto, B. Miličić, 1998, International journal of radiation oncology, biology, physics.

Elective ipsilateral neck irradiation of patients with locally advanced maxillary sinus carcinoma

B. Jeremic, Y. Shibamoto, B. Miličić, 2000, Cancer.

Pre-irradiation carboplatin and etoposide and accelerated hyperfractionated radiation therapy in patients with high-grade astrocytomas: a phase II study.

B. Jeremic, Y. Shibamoto, D. Grujičić, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Short-course Radiotherapy in Elderly and Frail Patients with Glioblastoma Multiforme. A Phase II Study

B. Jeremic, Y. Shibamoto, D. Grujičić, 1999, Journal of Neuro-Oncology.

Second cancers occurring in patients with early stage non-small-cell lung cancer treated with chest radiation therapy alone.

B. Jeremic, Y. Shibamoto, N. Nikolić, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial.

B. Jeremic, Y. Shibamoto, N. Nikolić, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Role o f R adiation T herapy i n t he C ombined-Modalit y Treatment o f P atients W ith E xtensive D isease Small-Cell L ung C ancer: A R andomized S tudy

B. Jeremic, Y. Shibamoto, B. Miličić, 1999 .

No thoracic radiation myelitis after spinal cord dose > or = 50.4 Gy using 1.2. Gy b.i.d. fractionation in patients with Stage III non-small cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapy.

B. Jeremic, Y. Shibamoto, B. Miličić, 2002, Lung cancer.

Hyperfractionated radiotherapy (Hfx RT) with or without concurrent low-dose daily cisplatin (CDDP) in locally advanced unresectable squamous cell carcinoma of the head and neck (SCC H&N). A prospective randomized trial

B. Jeremic, Y. Shibamoto, B. Miličić, 1999 .

[The effect of extent of tumor resection on the outcome of combined therapy in patients with glioblastoma multiforme].

B. Jeremic, B. Miličić, N. Nikolić, 1997, Srpski arhiv za celokupno lekarstvo.

Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial.

B. Jeremic, Y. Shibamoto, B. Miličić, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

P-279Cetuximab as third line treatment of metastatic colorectal carcinoma (mCRC) – 5-year experience from the Institute of Oncology and Radiology of Serbia

N. Nikolić, J. Spasić, V. Nikolic, 2015 .